Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFIRI pharmacogenomic marker study in metastatic colorectal cancer
ChiCTR-ONC-13004542Phase 4Recruiting
- Sponsor
- Sichuan Cancer Hospital
- Start
- Jun 2012
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of irinotecan, fluorouracil and folinic acid in colorectal cancer (CRC), sponsored by Sichuan Cancer Hospital. Primary endpoints: Safety and Time to progression. Started Jun 2012; status: recruiting.
02
Drugs
irinotecanfluorouracilfolinic acid
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR-ONC-13004542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-13004542.